Sandoz

Views & Analysis
Optimising market access for biosimilars

Optimising market access for biosimilars

We speak to Sandoz’s global head of biopharmaceuticals, Stefan Hendriks, about the remaining challenges in market access for biosimilars and what the future could hold for this still-bu

Digital
Developing with start-up DNA

Developing with start-up DNA

As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company and the wider industry.

Digital
Deep Dive Access and Commercialisation

Deep Dive: Access and Commercialisation

In this issue of Deep Dive we explore the ever present issues of market access and commercialisation, analysing recent changes in China, England and the US and asking how pharma can work with he